GLP1R and obesity due to melanocortin 4 receptor deficiency: Therefore, GLP-1 has demonstrated a role in renal protection trough modulation of lipid and energy metabolism, and it is supposed that GLP-1R agonists may be a promising therapy in obesity-associated CKD.